<?xml version='1.0' encoding='utf-8'?>
<document id="29766657"><sentence text="Drug-drug interaction and doping: Effect of non-prohibited drugs on the urinary excretion profile of methandienone."><entity charOffset="101-114" id="DDI-PubMed.29766657.s1.e0" text="methandienone" /></sentence><sentence text="The potential consequences of drug-drug interactions on the excretion profile of the anabolic androgenic steroid methandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one) are discussed"><entity charOffset="113-126" id="DDI-PubMed.29766657.s2.e0" text="methandienone" /><entity charOffset="128-173" id="DDI-PubMed.29766657.s2.e1" text="17β-hydroxy-17α-methylandrosta-1,4-dien-3-one" /><pair ddi="false" e1="DDI-PubMed.29766657.s2.e0" e2="DDI-PubMed.29766657.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29766657.s2.e0" e2="DDI-PubMed.29766657.s2.e1" /></sentence><sentence text=" More specifically, we have evaluated by in vitro and in vivo experiments the effects of 7 non-prohibited drugs (fluconazole, ketoconazole, itraconazole, miconazole, fluoxetine, paroxetine, and nefazodone) on the main metabolic pathways of methandienone"><entity charOffset="113-124" id="DDI-PubMed.29766657.s3.e0" text="fluconazole" /><entity charOffset="126-138" id="DDI-PubMed.29766657.s3.e1" text="ketoconazole" /><entity charOffset="140-152" id="DDI-PubMed.29766657.s3.e2" text="itraconazole" /><entity charOffset="154-164" id="DDI-PubMed.29766657.s3.e3" text="miconazole" /><entity charOffset="166-176" id="DDI-PubMed.29766657.s3.e4" text="fluoxetine" /><entity charOffset="178-188" id="DDI-PubMed.29766657.s3.e5" text="paroxetine" /><entity charOffset="194-204" id="DDI-PubMed.29766657.s3.e6" text="nefazodone" /><entity charOffset="240-253" id="DDI-PubMed.29766657.s3.e7" text="methandienone" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e0" e2="DDI-PubMed.29766657.s3.e0" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e0" e2="DDI-PubMed.29766657.s3.e1" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e0" e2="DDI-PubMed.29766657.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e0" e2="DDI-PubMed.29766657.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e0" e2="DDI-PubMed.29766657.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e0" e2="DDI-PubMed.29766657.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e0" e2="DDI-PubMed.29766657.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e0" e2="DDI-PubMed.29766657.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e1" e2="DDI-PubMed.29766657.s3.e1" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e1" e2="DDI-PubMed.29766657.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e1" e2="DDI-PubMed.29766657.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e1" e2="DDI-PubMed.29766657.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e1" e2="DDI-PubMed.29766657.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e1" e2="DDI-PubMed.29766657.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e1" e2="DDI-PubMed.29766657.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e2" e2="DDI-PubMed.29766657.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e2" e2="DDI-PubMed.29766657.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e2" e2="DDI-PubMed.29766657.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e2" e2="DDI-PubMed.29766657.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e2" e2="DDI-PubMed.29766657.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e2" e2="DDI-PubMed.29766657.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e3" e2="DDI-PubMed.29766657.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e3" e2="DDI-PubMed.29766657.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e3" e2="DDI-PubMed.29766657.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e3" e2="DDI-PubMed.29766657.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e3" e2="DDI-PubMed.29766657.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e4" e2="DDI-PubMed.29766657.s3.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e4" e2="DDI-PubMed.29766657.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e4" e2="DDI-PubMed.29766657.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e4" e2="DDI-PubMed.29766657.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e5" e2="DDI-PubMed.29766657.s3.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e5" e2="DDI-PubMed.29766657.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e5" e2="DDI-PubMed.29766657.s3.e7" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e6" e2="DDI-PubMed.29766657.s3.e6" /><pair ddi="false" e1="DDI-PubMed.29766657.s3.e6" e2="DDI-PubMed.29766657.s3.e7" /></sentence><sentence text=" These are selected among those most commonly used by the athletes" /><sentence text=" The in vitro assays were based on the use of human liver microsomes, specific recombinant enzyme isoforms of cytochrome P450 and uridine 5'-diphospho-glucuronosyl-transferase" /><sentence text=" The in vivo study was performed by analyzing urines collected after the oral administration of methandienone with and without the co-administration of ketoconazole"><entity charOffset="46-52" id="DDI-PubMed.29766657.s6.e0" text="urines" /><entity charOffset="96-109" id="DDI-PubMed.29766657.s6.e1" text="methandienone" /><entity charOffset="152-164" id="DDI-PubMed.29766657.s6.e2" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.29766657.s6.e0" e2="DDI-PubMed.29766657.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29766657.s6.e0" e2="DDI-PubMed.29766657.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29766657.s6.e0" e2="DDI-PubMed.29766657.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29766657.s6.e1" e2="DDI-PubMed.29766657.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29766657.s6.e1" e2="DDI-PubMed.29766657.s6.e2" /></sentence><sentence text=" Methandienone and its metabolites were determined by liquid chromatography-mass spectrometry-based techniques after sample pretreatment including an enzymatic hydrolysis step (performed only for the investigation on phase II metabolism) and liquid/liquid extraction with t-butyl methyl-ether"><entity charOffset="1-14" id="DDI-PubMed.29766657.s7.e0" text="Methandienone" /><entity charOffset="272-292" id="DDI-PubMed.29766657.s7.e1" text="t-butyl methyl-ether" /><pair ddi="false" e1="DDI-PubMed.29766657.s7.e0" e2="DDI-PubMed.29766657.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29766657.s7.e0" e2="DDI-PubMed.29766657.s7.e1" /></sentence><sentence text=" The results from the in vitro experiments showed that the formation of the hydroxylated and dehydrogenated metabolites was significantly reduced in the presence of itraconazole, ketoconazole, miconazole and nefazodone, whereas the production of the 18-nor-hydroxylated metabolites and glucuronidation reactions was reduced significantly only in the presence of ketoconazole and miconazole"><entity charOffset="165-177" id="DDI-PubMed.29766657.s8.e0" text="itraconazole" /><entity charOffset="179-191" id="DDI-PubMed.29766657.s8.e1" text="ketoconazole" /><entity charOffset="193-203" id="DDI-PubMed.29766657.s8.e2" text="miconazole" /><entity charOffset="208-218" id="DDI-PubMed.29766657.s8.e3" text="nefazodone" /><entity charOffset="362-374" id="DDI-PubMed.29766657.s8.e4" text="ketoconazole" /><entity charOffset="379-389" id="DDI-PubMed.29766657.s8.e5" text="miconazole" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e0" e2="DDI-PubMed.29766657.s8.e0" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e0" e2="DDI-PubMed.29766657.s8.e1" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e0" e2="DDI-PubMed.29766657.s8.e2" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e0" e2="DDI-PubMed.29766657.s8.e3" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e0" e2="DDI-PubMed.29766657.s8.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e0" e2="DDI-PubMed.29766657.s8.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e1" e2="DDI-PubMed.29766657.s8.e1" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e1" e2="DDI-PubMed.29766657.s8.e2" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e1" e2="DDI-PubMed.29766657.s8.e3" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e1" e2="DDI-PubMed.29766657.s8.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e1" e2="DDI-PubMed.29766657.s8.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e2" e2="DDI-PubMed.29766657.s8.e2" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e2" e2="DDI-PubMed.29766657.s8.e3" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e2" e2="DDI-PubMed.29766657.s8.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e2" e2="DDI-PubMed.29766657.s8.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e3" e2="DDI-PubMed.29766657.s8.e3" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e3" e2="DDI-PubMed.29766657.s8.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e3" e2="DDI-PubMed.29766657.s8.e5" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e4" e2="DDI-PubMed.29766657.s8.e4" /><pair ddi="false" e1="DDI-PubMed.29766657.s8.e4" e2="DDI-PubMed.29766657.s8.e5" /></sentence><sentence text=" The analysis of the post-administration samples confirmed the in vitro observations, validating the hypothesis that drug-drug interaction may cause significant alterations in the metabolic profile of banned drugs, making their detection during doping control tests more challenging" /><sentence text="" /></document>